Key facts
- Notable investors include Bridgewest Group.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for PharmAgent
- ·The full record, as it builds
Funding rounds
No funding rounds for PharmAgent are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About PharmAgent
Provider of an AI-driven pharmaceutical shortage intelligence platform designed to triangulate fragmented regulatory and supply-chain signals into insights for industry stakeholders. The company's intelligence layer unifies disparate global data streams through proprietary AI, enabling clients to act sooner, protect supply chains, and plan with greater confidence.
- Sector
- Healthcare
- HQ
- Auckland, New Zealand
- Founded
- 2025
- Ownership
- Privately Held (backing)
PharmAgent doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in PharmAgent shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on PharmAgent in its N-PORT filings yet. We sweep new filings monthly.